Skip to main content
. 2021 Oct 28;12:633880. doi: 10.3389/fpsyt.2021.633880

Table 8.

No medication effects on vigilance.

Stability Mean vigilance 0 A1 A2 A3 B1 B23
General use of medication (yes/no)
ADHD Z; p; r −0.71; 0.477; 0.05 −0.845; 0.398; 0.06 −0.543; 0.587; 0.04 −1.432; 0.152; 0.11 −0.628; 0.53; 0.05 −0.57; 0.568; 0.04 −0.763; 0.446; 0.06 −0.71; 0.477; 0.05
Depression Z; p; r −0.4; 0.689; 0.03 −0.918; 0.359; 0.07 −0.353; 0.724; 0.03 −0.735; 0.462; 0.06 −1.076; 0.282; 0.08 −0.871; 0.384; 0.07 −0.155; 0.877; 0.01 −0.4; 0.689; 0.03
Use of specific medication
ADHD H; p; η2 1.323; 0.516; 0.01 1.428; 0.49; 0.01 0.522; 0.77; 0.02 3.407; 0.182; 0.02 2.251; 0.324; 0 0.331; 0.847; 0.02 1.359; 0.507; 0.01 1.323; 0.516; 0.01
Depression H; p; η2 1.41; 0.5; 0.01 1.64; 0.44; 0 3.88; 0.14; 0.02 3.3; 0.19; 0.01 0.92; 0.63; 0.01 0.81; 0.67; 0.01 1.41; 0.5; 0.01 1.64; 0.44; 0

Here are shown the statistic results of the analysis of medication effect on vigilance measures. Analysis of general use (yes/no) of medication was performed with Mann–Whitney U-test. The use of specific medication was analyzed with Kruskal–Wallis test. Statistical parameter Z for Mann–Whitney, H for Kruskal–Wallis. Effect size parameter: r, Pearson's regression coefficient = Z/n and η2= (H – k + 1)/(n – k); n, number of subjects; k, number of groups (see Table 7).